Collegium Pharmaceuticals Inc., a Cumberland, R.I.-based developer of late-stage drugs that add market value and clinical benefit to existing products, has raised $5.5 million in Series C funding, according to a regulatory filing. Backers include Boston Millennia Partners and Westfield Capital Management. www.collegiumpharma.com
EyeGate Pharma, a Paris, France
Ardian Inc., a Menlo Park, Calif.-based developer of a medical device to treat congestive heart failure, has raised around $10.08 million in Series B-1 funding, according to a regulatory filing. Return backers include WS Investment Co. was joined by return backers Advanced Technology Ventures, Morgenthaler Ventures and St. Paul Venture Capital.
Eric Risley has joined Rutberg & Co. as senior managing director and head of I-banking. He previously ran the software corporate and I-banking group at Banc of America Securities. www.rutbergco.com
Duff & Phelps has acquired Chanin Capital Partners, a specialty I-bank specializing in distressed situations. No financial terms were disclosed. www.duffandphelps.com www.chanin.com
BIA Digital Partners II has received an SBIC license from the U.S. Small Business Administration. The fund currently has $105 million in committed capital, with a final close on $150 million scheduled for next month. It makes mezzanine investments in media, telecommunications, information and business service companies. www.biacapital.com
HitecVision Private Equity, a firm focused on oil and gas opportunities in Europe and North America, is opening a UK office in Aberdeen. It will be run by Mike Hill, a former director of 3i Group's oil and gas team. www.hitecvision.com
OpenView Venture Partners, a spinout of Insight Venture Partners' Boston office, reported to the SEC that limited partners in its $100 million inaugural fund include Commonfund, CalPERS, Hermes and Procific. www.openviewpartners.com
Avrio Ventures of Calgary, Alberta has held a Cnd$53 million first close on its inaugural fund. A second closing is planned for next year. The VC firm will focus on Canadian companies in the industrial bioproducts, food technology and nutraceutical ingredient spaces. www.avrioventures.com
North Castle Partners of Greenwich, Conn. is raising up to $300 million for its fourth fund, according to a regulatory filing. It already has secured $63.8 million in commitments, with Merrill Lynch serving as placement agent. www.northcastlepartners.com